PDUFA date of August 15th of 2025 set to review on whether or not TNX-102 SL should be approved to treat patients with Fibromyalgia. The company announced that the FDA will not require an Advisory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results